Naïve Th cells that are activated develop into Th1 cells that hamper tumor progression through the production of interleukin (IL)-2 and interferon-gamma (IFN-γ), which increases the phagocytosis of tumor cells and the antitumor immune response [79,80]. Here, IL2 is linked to neoplasm.